Swanbio Therapeutics
SwanBio is now part of Spur Therapeutics. Our potential first-in-class gene therapy candidate for adrenomyeloneuropathy (AMN) has joined Spur’s expanding pipeline of next-generation genetic medicines. Learn more at spurtherapeutics.com.
7-day free trial · no credit card
Verified contacts
7
available on Kipplo
LinkedIn employees
11 to 50
headcount range
Open roles
—
no listings
Distinct roles
7
indexed titles
Tech stack
1
tools in use
Monthly traffic
126
organic / mo
Sign up free to see all 7 verified contacts at Swanbio Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
7 contacts with verified email or phone · masked until revealed.
- MA
Michael Alexander
General Counsel & Head of Intellectual Property · Legal
EmailPhone - SC
Sean Clark
VP Vector Engineering and Bioassay · Information Technology
EmailPhone - OL
Olga Lozynska
Senior Scientist, Quality Control · Science
EmailPhone - MS
Meghan Stranick
Senior Manager Regulatory Affairs · Science
EmailPhone - XD
Xuefeng Deng
Senior Scientist, Process and Analytical Development · Other
EmailPhone
Showing 5 of 7 verified contacts
Top roles at Swanbio Therapeutics
7 distinct titles indexed · top 7 shown.
- 1, (), -,
- 1general counsel & head of intellectual property
- 1political analyst
- 1senior manager regulatory affairs
- 1senior scientist, process and analytical development
- 1senior scientist, quality control
- 1vp vector engineering and bioassay
Sign up to unlock all 7 contacts at Swanbio Therapeutics
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 7 verified contacts at Swanbio Therapeutics
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.